Acurx Pharmaceuticals (ACXP) Set to Announce Earnings on Wednesday

Acurx Pharmaceuticals (NASDAQ:ACXPGet Free Report) will be releasing its earnings data before the market opens on Wednesday, May 15th. Analysts expect Acurx Pharmaceuticals to post earnings of ($0.24) per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.

Acurx Pharmaceuticals (NASDAQ:ACXPGet Free Report) last issued its quarterly earnings data on Friday, March 15th. The company reported ($0.38) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.26) by ($0.12). On average, analysts expect Acurx Pharmaceuticals to post $-1 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Acurx Pharmaceuticals Trading Up 0.5 %

Shares of NASDAQ ACXP opened at $2.03 on Monday. Acurx Pharmaceuticals has a twelve month low of $1.17 and a twelve month high of $8.82. The stock has a 50 day moving average of $2.22 and a two-hundred day moving average of $3.19. The stock has a market cap of $31.99 million, a P/E ratio of -1.77 and a beta of -1.79.

Wall Street Analyst Weigh In

Separately, HC Wainwright reduced their price objective on Acurx Pharmaceuticals from $14.00 to $12.00 and set a “buy” rating for the company in a research note on Tuesday, March 19th.

View Our Latest Analysis on ACXP

About Acurx Pharmaceuticals

(Get Free Report)

Acurx Pharmaceuticals, Inc, a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections.

Recommended Stories

Earnings History for Acurx Pharmaceuticals (NASDAQ:ACXP)

Receive News & Ratings for Acurx Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acurx Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.